Cue Biopharma, Inc. (CUE) is a publicly traded Healthcare sector company. As of May 21, 2026, CUE trades at $20.03 with a market cap of $86.50M and a P/E ratio of -16.45. CUE moved -1.53% today. Year to date, CUE is +77.99%; over the trailing twelve months it is +1.70%. Its 52-week range spans $4.97 to $59.67. Rallies surfaces CUE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CUE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CUE recently traded at $20.03. Market cap is $86.50M. P/E ratio is -16.45. Revenue is $32.73M.
| Metric | Value |
|---|---|
| Price | $20.03 |
| Market Cap | $86.50M |
| P/E Ratio | -16.45 |
| EPS | $-1.21 |
| Dividend Yield | 0.00% |
| 52-Week High | $59.67 |
| 52-Week Low | $4.97 |
| Volume | 385 |
| Avg Volume | 0 |
| Revenue (TTM) | $32.73M |
| Net Income | $-19.52M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $27.47M | $-26.60M | $-0.28 |
| 2024 | $9.29M | $-40.67M | $-0.72 |
| 2023 | $5.49M | $-50.73M | $-1.11 |
| 2022 | $1.25M | $-53.01M | $-1.49 |
CUE analyst coverage data. Average price target: $0.00.